Elucidation of abacavir hypersensitivity syndrome in HIV-1 patients establishes a new pharmacogenetic paradigm. A drug can alter the bodies’ surface display of peptides bound to a given HLA molecule, thereby initiating life threatening T-cell reactions against self-peptides not previously exposed to the immune system.
展开▼